480 related articles for article (PubMed ID: 16831603)
1. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice.
Wang HH; Afdhal NH; Gendler SJ; Wang DQ
Gastroenterology; 2006 Jul; 131(1):210-22. PubMed ID: 16831603
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation.
Wang HH; Afdhal NH; Gendler SJ; Wang DQ
J Lipid Res; 2004 Mar; 45(3):438-47. PubMed ID: 14703511
[TBL] [Abstract][Full Text] [Related]
3. Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice.
Lammert F; Wang DQ; Wittenburg H; Bouchard G; Hillebrandt S; Taenzler B; Carey MC; Paigen B
Hepatology; 2002 Nov; 36(5):1145-54. PubMed ID: 12395324
[TBL] [Abstract][Full Text] [Related]
4. Absence of CFTR is associated with pleiotropic effects on mucins in mouse gallbladder epithelial cells.
Kuver R; Wong T; Klinkspoor JH; Lee SP
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1148-54. PubMed ID: 16825704
[TBL] [Abstract][Full Text] [Related]
5. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
Xu G; Zhao L; Fuchs M
Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
[TBL] [Abstract][Full Text] [Related]
6. Interacting QTLs for cholesterol gallstones and gallbladder mucin in AKR and SWR strains of mice.
Wittenburg H; Lammert F; Wang DQ; Churchill GA; Li R; Bouchard G; Carey MC; Paigen B
Physiol Genomics; 2002 Feb; 8(1):67-77. PubMed ID: 11842132
[TBL] [Abstract][Full Text] [Related]
7. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
8. Mucin gene expression in gallbladder epithelium.
Lee KT; Liu TS
J Formos Med Assoc; 2002 Nov; 101(11):762-8. PubMed ID: 12517055
[TBL] [Abstract][Full Text] [Related]
9. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder.
Finzi L; Barbu V; Burgel PR; Mergey M; Kirkwood KS; Wick EC; Scoazec JY; Peschaud F; Paye F; Nadel JA; Housset C
Am J Pathol; 2006 Dec; 169(6):2031-41. PubMed ID: 17148666
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of mucins in the cystic fibrosis mouse small intestine, and modulator effects of the Muc1 mucin expression.
Malmberg EK; Noaksson KA; Phillipson M; Johansson ME; Hinojosa-Kurtzberg M; Holm L; Gendler SJ; Hansson GC
Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G203-10. PubMed ID: 16500918
[TBL] [Abstract][Full Text] [Related]
11. Mucin genes in gallstone disease.
Chuang SC; Hsi E; Lee KT
Clin Chim Acta; 2012 Oct; 413(19-20):1466-71. PubMed ID: 22705400
[TBL] [Abstract][Full Text] [Related]
12. Mucin gene expression in gallbladder epithelium with black pigment stone ascertained by in situ hybridization.
Lee KT; Liu TS
Kaohsiung J Med Sci; 2001 Oct; 17(10):517-23. PubMed ID: 11831115
[TBL] [Abstract][Full Text] [Related]
13. Ground squirrel model for cholelithiasis: role of epithelial glycoproteins.
MacPherson BR; Pemsingh RS
Microsc Res Tech; 1997 Oct; 39(1):39-55. PubMed ID: 9329018
[TBL] [Abstract][Full Text] [Related]
14. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
[TBL] [Abstract][Full Text] [Related]
15. Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.
Seo KY; Chung SH; Lee JH; Park MY; Kim EK
Cornea; 2007 Jul; 26(6):709-14. PubMed ID: 17592322
[TBL] [Abstract][Full Text] [Related]
16. Gallbladder mucin as a pronucleating agent for cholesterol monohydrate crystals in bile.
Smith BF
Hepatology; 1990 Sep; 12(3 Pt 2):183S-186S; discussion 186S-188S. PubMed ID: 2210647
[TBL] [Abstract][Full Text] [Related]
17. C57BL/6 mice lacking Muc1 show no ocular surface phenotype.
Danjo Y; Hazlett LD; Gipson IK
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4080-4. PubMed ID: 11095599
[TBL] [Abstract][Full Text] [Related]
18. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
[TBL] [Abstract][Full Text] [Related]
19. Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.
Wang HH; Liu M; Portincasa P; Tso P; Wang DQ
Neurogastroenterol Motil; 2016 Mar; 28(3):364-75. PubMed ID: 26604077
[TBL] [Abstract][Full Text] [Related]
20. Ezetimibe prevents cholesterol gallstone formation in mice.
Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
